NCT03729063

Brief Summary

The main objective of this study is to show that the repeated (twice-daily) measurement of expired CO during hospitalization helps reduce smoking.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2018

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 2, 2018

Completed
17 days until next milestone

Study Start

First participant enrolled

November 19, 2018

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 16, 2019

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 29, 2020

Completed
Last Updated

December 31, 2020

Status Verified

December 1, 2020

Enrollment Period

1.1 years

First QC Date

October 31, 2018

Last Update Submit

December 29, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • % variation in expired CO

    Baseline to hospital discharge (expected maximum of 28 days)

Secondary Outcomes (4)

  • Length of hospital stays

    3 months

  • Smoking status (never, former current)

    Baseline (day 0)

  • Smoking status (never, former current)

    1 month

  • Smoking status (never, former current)

    3 months

Study Arms (2)

Twice daily expired CO measurements

EXPERIMENTAL

Patients included in this arm will have expired CO measurements every morning and evening during their initial hospitalization.

Other: Twice-daily expired carbon monoxide (CO) measurements

Control

ACTIVE COMPARATOR

Patients included in this arm will have one expired CO measurement on the morning just after initial hospital admission and a second expired CO measurement one the morning prior to discharge.

Other: Minimal control

Interventions

Patients included in this arm will have expired CO measurements every morning and evening during their initial hospitalization.

Twice daily expired CO measurements

Patients included in this arm will have one expired CO measurement on the morning just after initial hospital admission and a second expired CO measurement one the morning prior to discharge.

Control

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient hospitalized in pneumology for acute respiratory illness or scheduled hospitalization, for a minimum duration of 48h.
  • Signature of informed consent
  • Patient able to perform all visits and follow the procedures of the study
  • Affiliatedor beneficiary of French social security (national health insurance)

You may not qualify if:

  • Subject who can not read and / or write French
  • Expected travel that precludes study completion
  • Patient in palliative care
  • Inability to maintain apnea more than 8 seconds

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Arnaud de Villeneuve - CHU de Montpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Smoking

Interventions

Weights and Measures

Condition Hierarchy (Ancestors)

Behavior

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Officials

  • Jérémy Charriot, MD

    University Hospitals of Montpellier, France

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Model Details: This study is designed to compare one group of patients who had morning (6-8 am) and evening (5-7 pm) measurements of expired carbon monoxide (COexp) every day during their hospitalization (the twice-daily COexp group) versus a second group who had COexp measurements only the first morning following admission and the morning just prior to discharge (control group). A high potential for arm-contamination led the investigators to exclude a randomised design. The frequent COexp intervention was therefore deployed throughout months 1 and 3 of the four-month inclusion period, while the control intervention was deployed on months 2 and 4.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2018

First Posted

November 2, 2018

Study Start

November 19, 2018

Primary Completion

December 16, 2019

Study Completion

June 29, 2020

Last Updated

December 31, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations